Jove
Visualize
お問い合わせ

関連する概念動画

Proteomics01:33

Proteomics

9.7K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.7K
Therapeutic Index01:13

Therapeutic Index

6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
Stages of Infection01:26

Stages of Infection

65.2K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
65.2K
Stages of General Anesthesia01:22

Stages of General Anesthesia

1.6K
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.6K
Stages of Sleep01:22

Stages of Sleep

1.4K
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
1.4K
Therapeutic Communication01:30

Therapeutic Communication

7.9K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.9K
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  2. プロテオミクスは,早期肝細胞がんの新たな治療標的を特定する.
  1. ホーム
  2. プロテオミクスは,早期肝細胞がんの新たな治療標的を特定する.

関連する実験動画

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.5K

プロテオミクスは,早期肝細胞がんの新たな治療標的を特定する.

Ying Jiang1, Aihua Sun1, Yang Zhao1,2

  • 1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.

Nature
|March 1, 2019

PubMed で要約を見る

まとめ
この要約は機械生成です。

肝細胞癌 (HCC) のサブタイプは,プロテオミックプロファイリングを用いて特定されました. コレステロール障害とSOAT1発現の高さに関連したS- IIIサブタイプは予後が悪いが,アバシミブのようなSOAT1阻害剤に反応する可能性がある.

さらに関連する動画

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

12.8K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

776

関連する実験動画

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.5K
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

12.8K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

776

科学分野:

  • 腫瘍学
  • プロテオミクス
  • 分子生物学

背景:

  • 肝細胞癌 (HCC) は,特に東アジアでは,肝炎Bウイルス (HBV) 感染が主なリスク因子である主要な世界的な癌です.
  • 初期段階のHCCに対する手術の選択肢にもかかわらず,生存率は最適以下であり,より良い予後ツールと標的治療法の必要性を強調しています.

研究 の 目的:

  • プロテオミクおよびフォスフォプロテオミクプロファイリングを用いて早期のHBV関連肝細胞癌を分層する.
  • 異なる分子サブタイプとその臨床結果との関連を特定する.
  • HCCの進行と治療の可能性におけるステロールO-アチルトランスファーゼ1 (SOAT1) の役割を調査する.

主な方法:

  • 110のペア化された腫瘍および非腫瘍HCC組織のプロテオミックおよびフォスフォプロテオミックプロファイリング.
  • 患者様をサブタイプ (S-I,S-II,S-III) に分けるためのバイオ情報分析
  • アバシミブで治療された患者からの腫瘍異種移植マウスモデルを用いたSOAT1のインビトロノックダウン研究.

主要な成果:

  • プロテオミクスのデータは有意な異質性を明らかにし,異なる臨床結果を持つ3つのサブタイプ (S- I,S- II,S- III) に分層化することが可能となった.
  • S- IIIサブタイプは,コレステロールホメオスタシスの障害と高いSOAT1発現によって特徴づけられ,生存率の低下と術後の再発のリスクの増加と相関していました.
  • アバシミブ治療はSOAT1が高い異種移植における腫瘍の大きさを著しく減少させた.
  • 結論:

    • プロテオミック層化は,初期段階のHBV関連のHCCの生物学と異質性に関する新しい洞察を提供します.
    • S- IIIサブタイプは,SOAT1抑制によるコレステロール代謝を標的とした潜在的な治療的脆弱性を持つ高リスクグループを表しています.
    • この研究では,分子サブタイプとSOAT1発現に基づいて,HCCの個別化治療戦略を提案しています.